Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis
Shuxing Wang(Massachusetts General Hospital), Fang Wu(Central South University), Yurong Peng(Central South University), Yue Zeng(The University of Texas MD Anderson Cancer Center), Junqi Liu(First Affiliated Hospital of Zhengzhou University), Zhuqing Liu(Zhejiang University), Wentao Tian(Central South University), Sujuan Zhang(Central South University), Yunshu Li(Central South University)
Cited by 29
Related Papers
Cancer stem cells: advances in knowledge and implications for cancer therapy
|Signal Transduction and Targeted Therapy|2024|452
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
|Molecular Cancer|2023|194
Expression of Central Glucocorticoid Receptors after Peripheral Nerve Injury Contributes to Neuropathic Pain Behaviors in Rats
|Journal of Neuroscience|2004|118